Search Results - "drug development"

Postgraduate education and training in drug development sciences: 30 years of the european center of pharmaceutical medicine by Annette Mollet, Nastazja Laskowski, Thomas Szucs

Connect to this object online.

Model-Informed Drug Development: In Silico Assessment of Drug Bioperformance following Oral and Percutaneous Administration by Jelena Djuris, Sandra Cvijic, Ljiljana Djekic

Connect to this object online.

Integrating real‐world data to accelerate and guide drug development: A clinical pharmacology perspective by Xiaochen Zhao, Shahed Iqbal, Ivelisse L. Valdes, Mark Dresser, Sandhya Girish

Connect to this object online.

Clinical pharmacology applications in clinical drug development and clinical care: A focus on Saudi Arabia by Abdullah Alsultan, Wael A. Alghamdi, Jahad Alghamdi, Abeer F. Alharbi, Abdullah Aljutayli, Ahmed Albassam, Omar Almazroo, Saeed Alqahtani

Connect to this object online.

Leveraging patient‐centric sampling for clinical drug development and decentralized clinical trials: Promise to reality by Katie F. Maass, Matthew D. Barfield, Mototsugu Ito, Christopher A. James, Olga Kavetska, Marc Kozinn, Parag Kumar, Maureen Lepak, Luc Alexis Leuthold, Wenkui Li, Dmitri Mikhailov, Shefali Patel, Nisha L. Perez, Deanne Jackson Rudd, Blisse Vakkalagadda, Tracy M. Williams, Jiuhong Zha, Xin Zhang, Melanie D. Anderson

Connect to this object online.

A best practice framework for applying physiologically‐based pharmacokinetic modeling to pediatric drug development by Trevor N. Johnson, Ben G. Small, Eva Gil Berglund, Karen Rowland Yeo

Connect to this object online.

Soft Tissue and Bone Sarcoma

Subjects: “…drug development…”
DOAB: download the publication
DOAB: description of the publication

Application of the model‐informed drug development paradigm to datopotamab deruxtecan dose selection for late‐stage development by Yasong Lu, Shuang Liang, Ying Hong, Naoyuki Tajima, Kashyap Patel, Hanbin Li, David R. Wada, Jon Greenberg, Adam Petrich, Hong Zebger‐Gong, Dale Shuster, Pavan Vaddady

Connect to this object online.

Standards for model-based early bactericidal activity analysis and sample size determination in tuberculosis drug development by Laurynas Mockeliunas, Alan Faraj, Rob C. van Wijk, Caryn M. Upton, Gerben van den Hoogen, Andreas H. Diacon, Ulrika S. H. Simonsson

Connect to this object online.

Octopamine signaling in the metazoan pathogen Schistosoma mansoni: localization, small-molecule screening and opportunities for drug development by Nelly El-Sakkary, Steven Chen, Michelle R. Arkin, Conor R. Caffrey, Paula Ribeiro

Connect to this object online.

Quantitative Systems Pharmacology: An Exemplar Model‐Building Workflow With Applications in Cardiovascular, Metabolic, and Oncology Drug Development by Gabriel Helmlinger, Victor Sokolov, Kirill Peskov, Karen M. Hallow, Yuri Kosinsky, Veronika Voronova, Lulu Chu, Tatiana Yakovleva, Ivan Azarov, Daniel Kaschek, Artem Dolgun, Henning Schmidt, David W. Boulton, Robert C. Penland

Connect to this object online.

Drug development strategies for the treatment of obesity: how to ensure efficacy, safety, and sustainable weight loss by Barja-Fernandez S, Leis R, Casanueva FF, Seoane LM

Connect to this object online.

Empowering drug development: Leveraging insights from imaging technologies to enable the advancement of digital health technologies by Elena S. Izmailova, R. Paul Maguire, Timothy J. McCarthy, Martijn L. T. M. Müller, Philip Murphy, Diane Stephenson

Connect to this object online.

Editorial: Incorporating Phase 0 microdosing as a powerful tool into a new vision of drug development by H. Markus Weiss, Yuichi Sugiyama, Yuichi Sugiyama, Esther van Duijn

Connect to this object online.

Physiologically‐Based Pharmacokinetic Model‐Informed Drug Development for Fenebrutinib: Understanding Complex Drug‐Drug Interactions by Yuan Chen, Fang Ma, Nicholas S. Jones, Kenta Yoshida, Po‐Chang Chiang, Matthew R. Durk, Matthew R. Wright, Jin Yan Jin, Leslie W. Chinn

Connect to this object online.

Cross‐company collaboration to leverage analytics for clinical quality and accelerate drug development: The IMPALA industry group by Timothé Ménard, Kyle Young, Laura Siegel, Jennifer Emerson, Robert Studt, Leslie Sidor, The IMPALA Industry Group

Connect to this object online.

In Silico Molecular Docking and ADMET Analysis for Drug Development of Phytoestrogens Compound with Its Evaluation of Neurodegenerative Diseases by Faisal Akhmal Muslikh, Reyhan Rahma Samudra, Burhan Ma'arif, Zulvikar Syambani Ulhaq, Suko Hardjono, Mangestuti Agil

Connect to this object online.

Natural products in non-alcoholic fatty liver disease (NAFLD): Novel lead discovery for drug development by Lu Wang, Yonghuan Yan, Linfang Wu, Jinyong Peng

Connect to this object online.

Expression of drug transporters in the human skin: comparison in different species and models and its implication for drug development by Hanan Osman-Ponchet, Alexandre Gaborit, Jean-Michel Linget, Claire E. Wilson

Connect to this object online.

In vivo human keyhole limpet hemocyanin challenge in early phase drug development: A systematic review by Philip G. Drennan, Dimitrios Karponis, Duncan Richards, Mark Coles, James N. Fullerton

Connect to this object online.